MedTrace Logo

The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia

NCT00124384 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2008-04-23

No results posted yet for this study

Summary

This study examines how treatment with the drug modafinil, by itself or in combination with cognitive behavioral treatment for insomnia (CBT-I), may improve daytime functioning and/or diminish the severity of insomnia.

Conditions

  • Primary Insomnia

Interventions

BEHAVIORAL

CBT-I

DRUG

modafinil

Sponsors & Collaborators

  • Cephalon

    collaborator INDUSTRY

  • University of Rochester

    lead OTHER

Principal Investigators

  • Michael Perlis, PhD · University of Rochester Sleep Research Lab

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2007-08-31
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00124384 on ClinicalTrials.gov